Suman Paul MBBS, PhD

Dr. Suman Paul is an assistant professor of oncology at the Johns Hopkins School of Medicine where he treats patients suffering from leukemias and lymphomas. In his clinical practice, he experienced firsthand the lack of treatment options and the poor outcomes in patients with relapsed T cell leukemias and T cell lymphomas. Therefore, his laboratory research focuses on the development of new therapies for the treatment of these T-cell cancers. Using his background in T cell biology (Paul et al Immunity 2012, Paul et al Science Signaling 2014) and his collaborator's expertise in antibody design, he developed therapies that selectively kill T cell cancers and spare the majority of normal T cells (Paul et al. Sci. Transl. Med. 2021). His goal is to conduct the preclinical validation of the T cell cancer-targeting therapies so they can be tested in patients through early-phase clinical trials. They hope that their novel therapies will provide new treatment options and improve survival in patients with T-cell leukemias and lymphomas.